Title | Author(s) | Issue date | ???itemlist.??? |
Baseline cerebral oximetry values in cardiac and vascular surgery patients: a prospective observational study | Baikoussis, N. G.; Karanikolas, M.; Siminelakis, S.; Matsagas, M.; Papadopoulos, G. | 24-Nov-2015 | - |
Circulating matrix metalloproteinase 3 due to myocardial ischemia | Siminelakis, S.; Kotsanti, A.; Kolaitis, N.; Niokou, D.; Vlachou, I.; Dimakopoulos, G.; Papadopoulou, C. | 24-Nov-2015 | - |
Congenital hypopituitarism: monitoring after coronary artery bypass grafting | Siminelakis, S.; Kotsanti, A.; Baikoussis, N. G.; Andrikoula, M.; Bairaktari, E.; Papadopoulos, G. | 24-Nov-2015 | - |
Endovascular stent-graft repair as a late secondary procedure after previous aortic grafts | Matsagas, M. I.; Anagnostopoulos, C. E.; Papakostas, J. C.; DeRose, J. J.; Siminelakis, S.; Katsouras, C. S.; Toumpoulis, I. K.; Drossos, G. E.; Michalis, L. K. | 24-Nov-2015 | - |
Learning curves of cardiac surgery in relation to risk stratification and hospital location | Anagnostopoulos, C. E.; Siminelakis, S.; Ananiadou, O. G.; Katsaraki, A.; Drossos, G.; Katritsis, D.; Panagiotopoulos, J.; Papadopoulos, G. | 24-Nov-2015 | - |
Lyso platelet-activating factor accumulation in human arteries with atherosclerotic plaques | Tsoukatos, D. C.; Siminelakis, S. | 24-Nov-2015 | - |
Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study | Papadopoulos, G.; Sintou, E.; Siminelakis, S.; Koletsis, E.; Baikoussis, N. G.; Apostolakis, E. | 24-Nov-2015 | - |
Platelet-Activating Factor (Paf) Bioactivity Formation and Lyso-Paf Accumulation in Human Arteries | Tsoukatos, D. C.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Brocheriou, I.; Ninio, E.; Sismanidis, S.; Siminelakis, S. | 24-Nov-2015 | - |
Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery | Tsoukatos, D. C.; Brocheriou, I.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Sismanidis, S.; Ninio, E.; Siminelakis, S. | 24-Nov-2015 | - |
Platelet-activating factor bio-system in human arteries | Tsoukatos, D. C.; Brocheriou, I.; Ninio, E.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Sismanidis, S.; Siminelakis, S. | 24-Nov-2015 | - |
Possible mechanism for nitric oxide and oxidative stress induced pathophysiological variance in acute myocardial infarction development - A study by a flow injection-chemiluminescence method | Yao, D. C.; Vlessidis, A. G.; Evmiridis, N. P.; Siminelakis, S.; Dimitra, M. | 24-Nov-2015 | - |
The role of PAF-acetylhydrolase in the development of atherosclerosis | Tsoukatos, D. C.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussisis, S.; Brocheriou, I.; Ninio, E.; Sismanidis, S.; Siminelakis, S. | 24-Nov-2015 | - |
The systemic inflammatory response in coronary artery bypass grafting: what is the role of the very low ejection fraction (EF < or = 30%)? | Karfis, E. A.; Papadopoulos, G.; Matsagas, M.; Pantazi, D.; Lekka, M.; Kitsiouli, I.; Siminelakis, S.; Anagnostopoulos, C.E.; Drossos, G. | 24-Nov-2015 | - |
The systemic inflammatory response in coronary artery bypass grafting: what is the role of the very low ejection fraction (EF <= 30%)? | Karfis, E. A.; Papadopoulos, G.; Matsagas, M.; Pantazi, D.; Lekka, M.; Kitsiouli, I.; Siminelakis, S.; Anagnostopoulos, C. E.; Drossos, G. | 24-Nov-2015 | - |